MERILEE RAINES
CIK 1023869 · Executive VP & CFO · last filed 2026-05-22
MERILEE RAINES is an Executive VP & CFO who has filed 66 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for TMDX, was dated May 22, 2026. Across all open-market trades the lifetime net is −$38.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $21.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$21.23M
7
66
-$38.68M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TMDX | Director | 6,981 | $72.91 | $509.0K | $0 | 7 | 2026-05-22 |
| WTS | Director | 21,214 | $333.11 | $7.07M | $0 | 16 | 2025-08-05 |
| OCUL | Director | 46,933 | $8.94 | $419.6K | $0 | 5 | 2025-06-13 |
| BHE | Director | 24,489 | $89.93 | $2.20M | $0 | 3 | 2021-05-14 |
| ARATANA THERAPEUTICS, INC. (PETX) Delisted | Director | 0 | — | — | $0 | 7 | 2019-07-18 |
| AFFYMETRIX INC (AFFX) Delisted | Director | 0 | — | — | $0 | 3 | 2016-04-01 |
| IDXX | Executive VP & CFO | 19,666 | $560.88 | $11.03M | -$38.68M | 25 | 2013-02-27 |
Recent Filings
66 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-22 | TMDX | Grant (A) | +2,922 | $0 | EDGAR |
| 2025-08-05 | WTS | Grant (A) | +516 | $0 | EDGAR |
| 2025-06-13 | OCUL | Grant (A) | +14,000 | $0 | EDGAR |
| 2025-05-23 | TMDX | Grant (A) | +2,134 | $0 | EDGAR |
| 2024-08-05 | WTS | Grant (A) | +678 | $0 | EDGAR |
| 2024-07-26 | OCUL | Grant (A) | +12,000 | $0 | EDGAR |
| 2024-05-28 | TMDX | Grant (A) | +732 | $0 | EDGAR |
| 2023-07-31 | WTS | Grant (A) | +713 | $0 | EDGAR |
| 2023-06-16 | OCUL | Grant (A) | +12,000 | $0 | EDGAR |
| 2023-05-30 | TMDX | Grant (A) | +1,193 | $0 | EDGAR |